The myeloprotective effect of high dose medroxyprogesterone acetate (HD-MPA) in patients with carcinoma of the uterine cervix (stage II & III) treated by radiation

Supatra SangruchiMahidol University2018-07-042018-07-041996-12-01Journal of the Medical Association of Thailand. Vol.79, No.9 (1996)012522082-s2.0-18244418070https://repository.li.mahidol.ac.th/handle/20.500.14594/17661Mahidol UniversityMedicineThe myeloprotective effect of high dose medroxyprogesterone acetate (HD-MPA) in patients with carcinoma of the uterine cervix (stage II & III) treated by radiationArticleSCOPUS